Here are relevant reports on : route-optimization-market
-
Mainframe Modernization Market by Software (Application Modernization, Mainframe Optimization), Modernization Services (Application Modernization, Optimization, Operations, Mainframe-as-a-Service), Vertical, Region - Global Forecast to 2030
The mainframe modernization market is projected to expand from USD 8.39 billion in 2025 to USD 13.34 billion by 2030, at a CAGR of 9.7%, during the forecast period. The report profiles key players such as IBM (US), TCS (India), Capgemini (France), Atos (France), AWS (US), Micro Focus (UK), BMC Software (US), Infosys (India), Wipro (India), and HCL Tech (India).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Network Performance Optimization Market : Worldwide Market Forecast and Analysis (2014–2019)
Enterprise networks are continuously evolving into increasingly complex systems. They are dependent on reliable and robust performance of countless interconnected applications and devices. Networks have become the lifeblood of business and the conduit by which customers, partners, and employees share data and conduct business. Moreover, increased network complexity, converging technologies, and growing implementation of virtualization are expected to transform network management technologies, tools, and practices, and virtual networking installed as a part of server virtualization will progressively influence network managers. Network performance management includes monitoring, configuring, troubleshooting, controlling, and administrating the network-based business operations. The network performance management report covers various solutions such as bandwidth management, capacity planning and prediction management, and troubleshooting.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Petroleum Fuel Optimization Technologies Market - By Technologies and Geography: Trends & Forecasts to 2019
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Optimization Market: Worldwide Market Forecast and Analysis (2014–2019)
Enterprise networks are continuously evolving into increasingly complex systems. They are dependent on reliable and robust performance of countless interconnected applications and devices. Networks have become the lifeblood of business and the conduit by which customers, partners, and employees share data and conduct business. Moreover, increased network complexity, converging technologies, and growing implementation of virtualization are expected to transform network management technologies, tools, and practices, and virtual networking installed as a part of server virtualization will progressively influence network managers. Network performance management includes monitoring, configuring, troubleshooting, controlling, and administrating the network-based business operations. The network performance management report covers various solutions such as bandwidth management, capacity planning and prediction management, and troubleshooting.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Asia Pacific Vaccines market, valued at USD 9.46 billion in 2024, stood at USD 9.89 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of USD14.57 billion by the end of the period. The market is expanding quickly, driven by a rise in vaccine development and commercialization, heightened infectious disease rates, and the extensive use of preventive vaccines.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Elastomeric Pumps Market by Product (Continuous Rate, Variable Rate), Treatment (Chemotherapy, Antibiotic, Iron Chelation Therapy), Administration Route (Intravenous, Subcutaneous), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
The global elastomeric pumps market is expected to reach USD 592.0 Million by 2022 from USD 432.1 Million in 2017, growing at a CAGR of 6.5% from 2017 to 2022. Increasing number of surgeries, wide usage in treatment, rising incidence of chronic diseases, and increasing adoption for disposable infusion pumps, are some of the major driving factors driving the growth of the global elastomeric pumps market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Europe Contrast Media Market by Product (Microbubble, Iodine, Gadolinium, Barium-based), Modality (CT, MRI, Ultrasound), Indication (Cancer, GIT, CVD, Musculoskeletal, Neurology, Urology), Route of Administration (IV, Oral), End User - Forecast to 2031
The Europe contrast media market is projected to reach USD 3.19 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Immunotherapy Drugs Market by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
The global immunotherapy drugs market, valued at US$255.9 billion in 2023, stood at US$285.3 billion in 2024 and is projected to advance at a resilient CAGR of 15.3% from 2024 to 2029, culminating in a forecasted valuation of US$580.6 billion by the end of the period. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies.
- Published: July 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
